My Account Log in

2 options

Osteoporosis : assessment, prevalence and current treatment options / Elliott Burke, editor.

EBSCOhost Academic eBook Collection (North America) Available online

View online

EBSCOhost Ebook Medical Collection Available online

View online
Format:
Book
Contributor:
Burke, Elliott, editor.
Nova Biomedical (Publishing company), publisher.
Series:
Rheumatism and Musculoskeletal Disorders
Language:
English
Subjects (All):
Osteoporosis.
Osteoporosis--Diagnosis.
Osteoporosis--Treatment.
Physical Description:
1 online resource (248 p.)
Place of Publication:
New York : Nova Biomedical, 2016.
Summary:
Osteoporosis is a skeletal disorder characterized by low bone mass and the microdeterioration of bony tissue. In this book, Chapter One reviews the role and function of HDACs of different classes in different kinds of bone cells including osteoblasts and osteoclasts. Chapter Two evaluates the current state of research on mastocytosis-induced osteoporosis, and offers an overview of state of the art therapeutic measures. Chapter Three examines osteoporosis and the stomatognathic system. Chapter Four summarizes and critically appraises today's knowledge on osteoporosis from a dental perspective, and suggests directions for future research. Chapter Five discusses dental treatment of a patient with osteoporosis. Chapter Six reviews the treatment of osteoporotic fractures.
Contents:
OSTEOPOROSIS: ASSESSMENT, PREVALENCE AND CURRENT TREATMENT OPTIONS; OSTEOPOROSIS: ASSESSMENT, PREVALENCE AND CURRENT TREATMENT OPTIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: HDACS AND OSTEOPOROSIS; ABSTRACT; INTRODUCTION; HDACS AND BONE FORMATION; Class I HDACs and Bone Formation; HDAC1/HDAC2; HDAC3/HDAC8; Class II HDACs and Bone Formation; HDAC4/HDAC5; HDAC6/HDAC7; Class III HDACs and Bone Formation; HDACS AND BONE RESORPTION; Class I HDACs and Bone Resorption; HDAC2/HDAC3; Class II HDACs and Bone Resorption; HDAC6/HDAC7; HDAC9
Class III HDACs and Bone ResorptionCONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 2: MASTOCYTOSIS-INDUCED OSTEOPOROSIS: A RARE CAUSE FOR SECONDARY OSTEOPOROSIS; ABSTRACT; INTRODUCTION; MATERIALS AND METHODS; CONCLUSION; The Influence of Mast Cells on Bone; Mast Cells and Bone Turnover; Clinical Presentation of Mastocytosis-Induced Osteoporosis; Treatment Options; REFERENCES; Chapter 3: OSTEOPOROSIS AND THE STOMATOGNATHIC SYSTEM; ABSTRACT; 1. INTRODUCTION; 2. OSTEOPOROSIS; 3. THE STOMATOGNATHIC SYSTEM-ABOUT THE SYSTEM BONES; Maxilla/Jaw; Mandible; The Temporal-Mandibular Joint
4. THE RELATIONSHIP BETWEEN OSTEOPOROSISAND THE STOMATOGNATHIC SYSTEMBisphosphonates; 5. IMPLANTOLOGY AND OSTEOPOROSIS; Osteoporosis and the Teeth Loss; CONCLUSION; REFERENCES; Chapter 4: OSTEOPOROSIS AND JAWBONES: A DENTAL PERSPECTIVE; ABSTRACT; INTRODUCTION; DENTAL RADIOGRAPHS AS A SCREENING TOOLS FOR OSTEOPOROSIS; OSTEOPOROSIS AND THE ORAL CAVITY; Periodontitis; Dental Implants; Medication-Related Osteonecrosis of the Jaws (MRONJ); CONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 5: DENTAL TREATMENT OF A PATIENT WITH OSTEOPOROSIS; ABSTRACT; 1. INTRODUCTION; 2. BISPHOSPHONATES
3. ADVERSE EFFECTS OF BISPHOSPHONATE INTHE ORAL CAVITY3.1. Stomatitis; 3.2. Osteonecrosis of the Jaws; 3.3. Other Adverse Effects in the Oral Cavity; 4. USE OF BISPHOSPHONATES IN TREATMENT OF OROFACIAL PATHOLOGY; 4.1. Stomatological Treatment of Patients with Osteoporosis; 4.2. General Rules for Stomatological Treatment of the So- Called Risk Patients; 4.2.1. History (Anamnesis); 4.2.2. Laboratory Tests; 4.2.3. Plan of Therapy; 4.2.4. Timing of Dental Interventions; 4.2.5. Local Anesthesia; 4.2.6. Patient-Related Issues; 4.2.7. Restorative Dentistry and Prosthodontics; 4.2.8. Endodontics
4.2.9. Management of Periodontal Diseases4.2.10. Orthodontics; 4.2.11. Oral and Maxillofacial Surgery; 4.2.11.1. Aftercare Instructions for the Patient; 4.2.12. Implant Placement and Maintenance; CONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 6: TREATMENT OF OSTEOPOROTIC FRACTURES: WE NEED MORE THAN FRACTURE CARE; ABSTRACT; THE PUBLIC HEALTH BURDEN OF OSTEOPOROSIS; Pharmacologic Treatment; Bisphosphonates; Denosumab; Strontium Ranelate; Bone Anabolic Agents; Secondary Fracture Prevention; Health Care Delivery Models for Secondary Prevention of Low Trauma Fracture
Current Effectiveness of Secondary Prevention of Osteoporosis
Notes:
Description based upon print version of record.
Includes bibliographical references and index.
Description based on print version record.
ISBN:
1-63485-551-5

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Library Catalog Using Articles+ Library Account